v3.25.2
Condensed Consolidated Statements of Changes in Equity and Income (unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Capital in Excess of Par
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2023     128,369,000        
Beginning balance at Dec. 31, 2023 $ 1,547,718 $ 1,288,304 $ 128 $ 493,413 $ 751,856 $ 42,907 $ 259,414
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 96,897 96,897     96,897    
Net income attributable to non-controlling interests 17,845 0         17,845
Cash dividends declared for common stockholders (16,045) (16,045)     (16,045)    
Issuance of restricted stock (in shares)     1,000        
Issuance of restricted stock 0 0 $ 0 0      
Forfeitures of unvested restricted stock (in shares)     (12,000)        
Forfeitures of unvested restricted stock 14 14 $ 0 0 14    
Vesting of restricted stock 11,596 11,596   11,596      
Issuance of non-controlling interests 4,002 0         4,002
Distributions to and purchases of non-controlling interests (10,506) 394   394     (10,900)
Redemption value adjustment on non-controlling interests (1,901) (1,901)     (1,901)    
Other comprehensive loss (11,977) (11,977)       (11,977)  
Ending balance (in shares) at Mar. 31, 2024     128,358,000        
Ending balance at Mar. 31, 2024 1,637,643 1,367,282 $ 128 505,403 830,821 30,930 270,361
Beginning balance (in shares) at Dec. 31, 2023     128,369,000        
Beginning balance at Dec. 31, 2023 1,547,718 1,288,304 $ 128 493,413 751,856 42,907 259,414
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 174,460            
Ending balance (in shares) at Jun. 30, 2024     130,026,000        
Ending balance at Jun. 30, 2024 1,706,965 1,416,589 $ 130 519,280 891,397 5,782 290,376
Beginning balance (in shares) at Mar. 31, 2024     128,358,000        
Beginning balance at Mar. 31, 2024 1,637,643 1,367,282 $ 128 505,403 830,821 30,930 270,361
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 77,563 77,563     77,563    
Net income attributable to non-controlling interests 14,863 0         14,863
Cash dividends declared for common stockholders (16,254) (16,254)     (16,254)    
Issuance of restricted stock (in shares)     1,725,000        
Issuance of restricted stock 0 0 $ 2 (2)      
Forfeitures of unvested restricted stock (in shares)     (6,000)        
Forfeitures of unvested restricted stock 6 6 $ 0 0 6    
Vesting of restricted stock 14,408 14,408   14,408      
Repurchase of common shares (in shares)     (51,000)        
Repurchase of common shares (1,400) (1,400)   (529) (871)    
Issuance of non-controlling interests 9,750 0         9,750
Distributions to and purchases of non-controlling interests (4,598) 0         (4,598)
Redemption value adjustment on non-controlling interests 132 132     132    
Other comprehensive loss (25,148) (25,148)       (25,148)  
Ending balance (in shares) at Jun. 30, 2024     130,026,000        
Ending balance at Jun. 30, 2024 $ 1,706,965 1,416,589 $ 130 519,280 891,397 5,782 290,376
Beginning balance (in shares) at Dec. 31, 2024 128,962,850   128,963,000        
Beginning balance at Dec. 31, 2024 $ 1,986,928 1,681,355 $ 129 911,080 770,146 0 305,573
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 56,681 56,681     56,681    
Net income attributable to non-controlling interests 16,288 0         16,288
Cash dividends declared for common stockholders (8,060) (8,060)     (8,060)    
Issuance of restricted stock (in shares)     1,000        
Issuance of restricted stock 0 0 $ 0 0      
Vesting of restricted stock 3,892 3,892   3,892      
Repurchase of common shares (in shares)     (650,000)        
Repurchase of common shares (11,389) (11,389) $ (1) (6,104) (5,284)    
Issuance of non-controlling interests 7,944 0         7,944
Distributions to and purchases of non-controlling interests (12,183) 0         (12,183)
Redemption value adjustment on non-controlling interests 21 21     21    
Other comprehensive loss (3,106) (3,106)       (3,106)  
Ending balance (in shares) at Mar. 31, 2025     128,314,000        
Ending balance at Mar. 31, 2025 $ 2,037,016 1,719,394 $ 128 908,868 813,504 (3,106) 317,622
Beginning balance (in shares) at Dec. 31, 2024 128,962,850   128,963,000        
Beginning balance at Dec. 31, 2024 $ 1,986,928 1,681,355 $ 129 911,080 770,146 0 305,573
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation $ 97,252            
Ending balance (in shares) at Jun. 30, 2025 122,775,718   122,776,000        
Ending balance at Jun. 30, 2025 $ 1,990,769 1,667,041 $ 123 867,347 804,728 (5,157) 323,728
Beginning balance (in shares) at Mar. 31, 2025     128,314,000        
Beginning balance at Mar. 31, 2025 2,037,016 1,719,394 $ 128 908,868 813,504 (3,106) 317,622
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 40,571 40,571     40,571    
Net income attributable to non-controlling interests 16,116 0         16,116
Cash dividends declared for common stockholders (7,885) (7,885)     (7,885)    
Issuance of restricted stock (in shares)     256,000        
Issuance of restricted stock 0 0 $ 0 0      
Vesting of restricted stock 4,032 4,032   4,032      
Repurchase of common shares (in shares)     (5,794,000)        
Repurchase of common shares (87,076) (87,076) $ (5) (45,609) (41,462)    
Issuance of non-controlling interests 2,962 0         2,962
Distributions to and purchases of non-controlling interests (12,916) 56   56     (12,972)
Other comprehensive loss $ (2,051) (2,051)       (2,051)  
Ending balance (in shares) at Jun. 30, 2025 122,775,718   122,776,000        
Ending balance at Jun. 30, 2025 $ 1,990,769 $ 1,667,041 $ 123 $ 867,347 $ 804,728 $ (5,157) $ 323,728